ID   P5CR3_HUMAN             Reviewed;         274 AA.
AC   Q53H96; B3KMB5; B4DVT6; H0Y6C3; Q8N3N9; Q96HX4; Q9H896;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-NOV-2014, sequence version 3.
DT   10-MAY-2017, entry version 112.
DE   RecName: Full=Pyrroline-5-carboxylate reductase 3;
DE            Short=P5C reductase 3;
DE            Short=P5CR 3;
DE            EC=1.5.1.2 {ECO:0000269|PubMed:23024808};
DE   AltName: Full=Pyrroline-5-carboxylate reductase-like protein;
GN   Name=PYCRL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Spleen, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-150.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-264 (ISOFORM 1), AND
RP   VARIANT ASN-150.
RC   TISSUE=Brain;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 31-274 (ISOFORM 1), AND
RP   VARIANT ASN-150.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC
RP   ACTIVITY, FUNCTION, AND ENZYME REGULATION.
RX   PubMed=23024808; DOI=10.1371/journal.pone.0045190;
RA   De Ingeniis J., Ratnikov B., Richardson A.D., Scott D.A.,
RA   Aza-Blanc P., De S.K., Kazanov M., Pellecchia M., Ronai Z.,
RA   Osterman A.L., Smith J.W.;
RT   "Functional specialization in proline biosynthesis of melanoma.";
RL   PLoS ONE 7:E45190-E45190(2012).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Enzyme that catalyzes the last step in proline
CC       biosynthesis. Proline is synthesized from either glutamate or
CC       ornithine; both are converted to pyrroline-5-carboxylate (P5C),
CC       and then to proline via pyrroline-5-carboxylate reductases
CC       (PYCRs). PYCRL is exclusively linked to the conversion of
CC       ornithine to proline. {ECO:0000269|PubMed:23024808}.
CC   -!- CATALYTIC ACTIVITY: L-proline + NAD(P)(+) = 1-pyrroline-5-
CC       carboxylate + NAD(P)H. {ECO:0000269|PubMed:23024808}.
CC   -!- ENZYME REGULATION: Not inhibited by proline.
CC       {ECO:0000269|PubMed:23024808}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.42 mM for NADH {ECO:0000269|PubMed:23024808};
CC         KM=0.37 mM for NADPH {ECO:0000269|PubMed:23024808};
CC         KM=4.64 mM for pyrroline-5-carboxylate (in the presence of NADH)
CC         {ECO:0000269|PubMed:23024808};
CC         KM=0.38 mM for pyrroline-5-carboxylate (in the presence of
CC         NADPH) {ECO:0000269|PubMed:23024808};
CC         Note=kcat is 197 sec(-1) for the NADH-dependent reduction
CC         reduction of pyrroline-5-carboxylate. kcat is 35 sec(-1) for the
CC         NADPH-dependent reduction of pyrroline-5-carboxylate.
CC         {ECO:0000269|PubMed:23024808};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-
CC       proline from L-glutamate 5-semialdehyde: step 1/1.
CC       {ECO:0000269|PubMed:23024808}.
CC   -!- SUBUNIT: Homodecamer; composed of 5 homodimers.
CC       {ECO:0000250|UniProtKB:P32322}.
CC   -!- INTERACTION:
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-2959680, EBI-727004;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23024808}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q53H96-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q53H96-2; Sequence=VSP_057219;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the pyrroline-5-carboxylate reductase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD96405.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAD96405.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001500; BAG50927.1; -; mRNA.
DR   EMBL; AK023914; BAB14721.1; -; mRNA.
DR   EMBL; AK301225; BAG62798.1; -; mRNA.
DR   EMBL; AC067930; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007993; AAH07993.1; -; mRNA.
DR   EMBL; AK222685; BAD96405.1; ALT_SEQ; mRNA.
DR   EMBL; AL833857; CAD38716.1; -; mRNA.
DR   RefSeq; NP_001316795.1; NM_001329866.1.
DR   RefSeq; NP_075566.2; NM_023078.4.
DR   UniGene; Hs.165186; -.
DR   ProteinModelPortal; Q53H96; -.
DR   SMR; Q53H96; -.
DR   BioGrid; 122418; 23.
DR   IntAct; Q53H96; 6.
DR   STRING; 9606.ENSP00000220966; -.
DR   DrugBank; DB00172; L-Proline.
DR   iPTMnet; Q53H96; -.
DR   PhosphoSitePlus; Q53H96; -.
DR   BioMuta; PYCRL; -.
DR   DMDM; 172046829; -.
DR   EPD; Q53H96; -.
DR   PaxDb; Q53H96; -.
DR   PeptideAtlas; Q53H96; -.
DR   PRIDE; Q53H96; -.
DR   DNASU; 65263; -.
DR   Ensembl; ENST00000433751; ENSP00000404493; ENSG00000104524. [Q53H96-2]
DR   Ensembl; ENST00000495276; ENSP00000480945; ENSG00000104524. [Q53H96-1]
DR   Ensembl; ENST00000631620; ENSP00000488877; ENSG00000276657. [Q53H96-2]
DR   Ensembl; ENST00000632107; ENSP00000488371; ENSG00000276657. [Q53H96-1]
DR   GeneID; 65263; -.
DR   KEGG; hsa:65263; -.
DR   UCSC; uc064rcg.1; human. [Q53H96-1]
DR   CTD; 65263; -.
DR   GeneCards; PYCRL; -.
DR   H-InvDB; HIX0007842; -.
DR   HGNC; HGNC:25846; PYCRL.
DR   HPA; HPA063416; -.
DR   HPA; HPA069706; -.
DR   MIM; 616408; gene.
DR   neXtProt; NX_Q53H96; -.
DR   OpenTargets; ENSG00000104524; -.
DR   PharmGKB; PA134889043; -.
DR   eggNOG; KOG3124; Eukaryota.
DR   eggNOG; COG0345; LUCA.
DR   GeneTree; ENSGT00390000007443; -.
DR   HOGENOM; HOG000230247; -.
DR   HOVERGEN; HBG053399; -.
DR   InParanoid; Q53H96; -.
DR   KO; K00286; -.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   UniPathway; UPA00098; UER00361.
DR   GenomeRNAi; 65263; -.
DR   PRO; PR:Q53H96; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104524; -.
DR   CleanEx; HS_PYCRL; -.
DR   ExpressionAtlas; Q53H96; baseline and differential.
DR   Genevisible; Q53H96; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0004735; F:pyrroline-5-carboxylate reductase activity; IDA:UniProtKB.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0055129; P:L-proline biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_01925; P5C_reductase; 1.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR028939; P5C_Rdtase_cat_N.
DR   InterPro; IPR029036; P5CR_dimer.
DR   InterPro; IPR000304; Pyrroline-COOH_reductase.
DR   PANTHER; PTHR11645; PTHR11645; 1.
DR   Pfam; PF03807; F420_oxidored; 1.
DR   Pfam; PF14748; P5CR_dimer; 1.
DR   PIRSF; PIRSF000193; Pyrrol-5-carb_rd; 1.
DR   SUPFAM; SSF48179; SSF48179; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00112; proC; 1.
DR   PROSITE; PS00521; P5CR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Amino-acid biosynthesis;
KW   Complete proteome; Cytoplasm; NADP; Oxidoreductase; Polymorphism;
KW   Proline biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    274       Pyrroline-5-carboxylate reductase 3.
FT                                /FTId=PRO_0000324561.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ     113    132       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057219.
FT   VARIANT      57     57       R -> Q (in dbSNP:rs11549789).
FT                                /FTId=VAR_039828.
FT   VARIANT     105    105       V -> M (in dbSNP:rs2242089).
FT                                /FTId=VAR_039829.
FT   VARIANT     150    150       K -> N (in dbSNP:rs2242090).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_039830.
SQ   SEQUENCE   274 AA;  28663 MW;  846FDEC603F3B548 CRC64;
     MAAAEPSPRR VGFVGAGRMA GAIAQGLIRA GKVEAQHILA SAPTDRNLCH FQALGCRTTH
     SNQEVLQSCL LVIFATKPHV LPAVLAEVAP VVTTEHILVS VAAGVSLSTL EELLPPNTRV
     LRVLPNLPCV VQEGAIVMAR GRHVGSSETK LLQHLLEACG RCEEVPEAYV DIHTGLSGSG
     VAFVCAFSEA LAEGAVKMGM PSSLAHRIAA QTLLGTAKML LHEGQHPAQL RSDVCTPGGT
     TIYGLHALEQ GGLRAATMSA VEAATCRAKE LSRK
//
